The drug discovery and development firm is to establish a 74,000 sq ft drug development facility at Alderley Park, Cheshire, bringing together three subsidiary businesses onto one site.

The company has reached an agreement with Manchester Science Partnerships, which will see Alderley Park become the new home for Redx Oncology.

The business develops anti-cancer drugs and is currently based within the Royal Liverpool Hospital’s Duncan Building, which is due to be demolished in 2017.

Read more from Place Northwest here.